Table 4.
Parameters | WBC group | KT group | p | |
---|---|---|---|---|
MDA (p) [μmol/l] |
Before | 2.66 ± 0.73 | 2.32 ± 0.60 | 0.157 |
After | 2.48 ± 0.57 | 2.41 ± 0.83 | 0.783 | |
P ∗ | 0.215 | 0.959 | ||
Δ | −0.19 ± 0.72 | 0.09 ± 1.04 | 0.391 | |
| ||||
MDA (e) [nmol/gHb] |
Before | 0.16 ± 0.01 | 0.18 ± 0.02 | 0.001 |
After | 0.15 ± 0.02 | 0.18 ± 0.04 | 0.001 | |
P ∗ | 0.098 | 0.642 | ||
Δ | −0.01 ± 0.03 | 0.00 ± 0.04 | 0.155 | |
| ||||
TOS (s) [μmol/l] |
Before | 30.49 ± 13.35 | 23.94 ± 11.60 | 0.149 |
After | 14.56 ± 9.01 | 24.41 ± 6.24 | 0.001 | |
P ∗ | 0.003 | 0.605 | ||
Δ | −15.93 ± 17.04 | 0.46 ± 9.11 | 0.003 | |
| ||||
OSI (p/s) [arbitrary unit] |
Before | 64.19 ± 65.93 | 18.87 ± 11.30 | 0.016 |
After | 10.20 ± 3.79 | 23.65 ± 15.68 | 0.004 | |
P ∗ | 0.001 | 0.301 | ||
Δ | −53.99 ± 66.83 | 4.78 ± 13.88 | 0.003 |
P: statistical significance of differences between both groups of patients; P∗: statistical significance of differences between values before and after treatment in particular groups of patients.